SEARCH

SEARCH BY CITATION

References

  • 1
    Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245252.
  • 2
    Kalinski, P., Hilkens, C. M., Wierenga, E. A., and Kapsenberg, M. L., T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 1999. 20: 561567.
  • 3
    Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B. et al., Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007. 8: 950957.
  • 4
    van Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W., Muller, F. J., Hommes, D. W., Zaat, S. A. J., Kapsenberg, M. L. et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007. 27: 660669.
  • 5
    de Jong, E. C., Vieira, P. L., Kalinski, P., Schuitemaker, J. H., Tanaka, Y., Wierenga, E. A., Yazdanbakhsh, M. et al., Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 2002. 168: 17041709.
  • 6
    Kalinski, P., Schuitemaker, J. H., Hilkens, C. M., and Kapsenberg, M. L., Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 1998. 161: 28042809.
  • 7
    Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T. et al., Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 1996. 26: 16471651.
  • 8
    Rea, D., van Kooten, C., van Meijgaarden, K. E., Ottenhoff, T. H., Melief, C. J.., and Offringa, R., Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 2000. 95: 31623167.
  • 9
    Gauzzi, M. C., Purificato, C., Donato, K., Jin, Y., Wang, L., Daniel, K. C., Maghazachi, A. A. et al., Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J. Immunol. 2005. 174: 270276.
  • 10
    Xia, C. Q., Peng, R., Beato, F. and Clare-Salzler, M. J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 2005. 62: 4554.
  • 11
    Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R. et al., In vitro generation of Interleukin 10-producing regulatory CD4+ T Cells is induced by immunosuppressive drugs and inhibited by T helper Type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002. 195: 603616.
  • 12
    Griffin, M. D., Lutz, W. H., Phan, V. A., Bachman, L. A., McKean, D. J., and Kumar, R., Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 2000. 270: 701708.
  • 13
    van Duivenvoorde, L. M., Han, W. G., Bakker, A. M., Louis-Plence, P., Charbonnier, L. M., Apparailly, F., van der Voort, E. I. H. et al., Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J. Immunol. 2007. 179: 15061515.
  • 14
    Xing, N., Maldonado, L., Bachman, L. A., Kumar, R., and Griffin, M. D., Distinctive dendritic cell modulation by vitamin D3 and glucocorticoid pathways. Biochem. Biophys. Res. Commun. 2002. 297: 645652.
  • 15
    Canning, M. O., Grotenhuis, K., de Wit, H., Ruwhof, C., and Drexhage, H. A., 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 2001. 145: 351357.
  • 16
    Roelen, D. L., Schuurhuis, D. H., van den Boogaardt, D. E., Koekkoek, K., van Miert, P. P., van Schip, J., Laban, S. et al., Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 2003. 76: 16081615.
  • 17
    Woltman, A. M., de Fijter, J. W., Kamerling, S. W., Paul, L. C., Daha, M. R., and van Kooten, C., The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 2000. 30: 18071812.
  • 18
    Emmer, P. M., van der Vlag, J., Adema, G. J., Hilbrands, L. B., Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 2006. 81: 14511459.
  • 19
    Vizzardelli, C., Pavelka, N., Luchini, A., Zanoni, I., Bendickson, L., Pelizzola, M., Beretta, O. et al., Effects of dexamethazone on LPS-induced activation and migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur. J. Immunol. 2006. 36: 15041515.
  • 20
    Penna, G. and Adorini, L., 1alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000. 164: 24052411.
  • 21
    Piemonti, L., Monti, P., Sironi, M., Fraticelli, P., Leone, B. E., Dal Cin, E., Allavena, P. et al., Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000. 164: 44434451.
  • 22
    van Halteren, A. G., van Etten, E., de Jong, E. C., Bouillon, R., Roep, B. O. and Mathieu, C., Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an Analog of 1,25 dihydroxyvitamin D3. Diabetes 2002. 51: 21192125.
  • 23
    van Halteren, A. G., Tysma, O. M., van Etten, E., Mathieu, C., and Roep, B. O., 1[alpha],25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J. Autoimmun. 2004. 23: 233239.
  • 24
    Penna, G., Roncari, A., Amuchastegui, S., Daniel, K. C., Berti, E., Colonna, M., and Adorini, L., Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005. 106: 34903497.
  • 25
    Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., and Enk, A. H., Induction of Interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000. 192: 12131222.
  • 26
    Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., and Roncarolo, M. G., Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005. 105: 11621169.
  • 27
    Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C. et al., Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998. 281: 11911193.
  • 28
    Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N. et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 10271034.
  • 29
    Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y. et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261268.
  • 30
    Suh, W. K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S. et al., The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 2003. 4: 899906.
  • 31
    Sica, G. L., Choi, I. H., Zhu, G., Tamada, K., Wang, S. D., Tamura, H., Chapoval, A. I. et al., B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003. 18: 849861.
  • 32
    Abe, M., Wang, Z., de Creus, A. and Thomson, A. W., Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 2005. 5: 18081819.
  • 33
    Carter, L. L., Leach, M. W., Azoitei, M. L., Cui, J., Pelker, J. W., Jussif, J., Benoit, S. et al., PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007. 182: 124134.
  • 34
    Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M. et al., Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006. 203: 883895.
  • 35
    Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K. et al., PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 1069110696.
  • 36
    Okazaki, T. and Honjo, T., PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 2007. 19: 813824.
  • 37
    Sun, Y., Chen, H. M., Subudhi, S. K., Chen, J., Koka, R., Chen, L., and Fu, Y. X. et al., Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat. Med. 2002. 8: 14051413.
  • 38
    Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., Suh, J. H., Choi, B. K. et al., 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 2004. 10: 10881094.
  • 39
    Lee, S. W., Vella, A. T., Kwon, B. S., and Croft, M., Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J. Immunol. 2005. 174: 68036808.
  • 40
    Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O., and Acha-Orbea, H., Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA 1990. 87: 968972.
  • 41
    Firestein, G. S., Evolving concepts of rheumatoid arthritis. Nature 2003. 423: 356361.
  • 42
    Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J. et al., Infliximab (chimeric anti-tumour necrosis factor [alpha] monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. Lancet 1999. 354: 19321939.
  • 43
    Ehlers, S., Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF. Ann. Rheum. Dis. 2003. 62: ii37ii47.
  • 44
    Sawitzki, B., Kingsley, C. I., Oliveira, V., Karim, M., Herber, M., and Wood, K. J., IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 2005. 201: 19251935.
  • 45
    Roncarolo, M. G., Bachetta, R., Bordignon, C., Narula, S., and Levings, M. K., Type 1 T regulatory cells. Immunol. Rev. 2002. 182: 6879.
  • 46
    Rhode, A., Pauza, M. E., Barral, A. M., Rodrigo, E., Oldstone, M. B. A., von Herrath, M. G., and Christen, U., Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J. Immunol. 2005. 175: 35163524.
  • 47
    van Halteren, A. G., Kardol, M. J., Mulder, A. and Roep, B. O., Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice. Diabetologia 2005. 48: 7582.
  • 48
    Anderson, A. E., Swan, D. J., Sayers, B. L., Harry, R. A., Patterson, A. M., von Delwig, A., Robinson, J. H. et al., LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J. Leukoc. Biol. 2009. 85: 243250.
  • 49
    Szeles, L., Keresztes, G., Torocsik, D., Balajthy, Z., Krenacs, L., Poliska, S., Steinmeyer, A. et al., 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol. 2009. 182: 20742083.
  • 50
    Penna, G., Amuchastegui, S., Giarratana, N., Daniel, K. C., Vulcano, M., Sozzani, S. and Adorini, L., 1,25-dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 2007. 178: 145153.
  • 51
    Tokita, D., Mazariegos, G. V., Zahorchak, A. F., Chien, N., Abe, M., Raimondi G. and Thomson, A. W., High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008. 85: 369377.
  • 52
    Chen, C., Qu, Q. X., Huang, J. A., Zhu, Y. B., Ge, Y., Wang, Q., and Zhang, X. G., Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells. Immunobiology 2007. 212: 159165.
  • 53
    Selenko-Gebauer, N., Majdic, O., Szekeres, A., Hofler, G., Guthann, E., Korthauer, U., Zlabinger, G. et al., B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 2003. 170: 36373644.
  • 54
    Benedict, C. A., Loewendorf, A., Garcia, Z., Blazar, B. R., and Janssen, E. M., Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J. Immunol. 2008. 180: 48364847.
  • 55
    Kuipers, H., Muskens, F., Willart, M., Hijdra, D., van Assema, F. B., Coyle, A. J., Hoogsteden, H. C. et al. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur. J. Immunol. 2006. 36: 24722482.
  • 56
    Garonne, P., Neidhardt, M., Garcia, E., Galibert, M., van Kooten, C. and Banchereau, J., Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 2005. 182: 12651273.
  • 57
    Lyons, A. B., Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol Meth. 2000. 243: 147154.
  • 58
    Laich, A., Neurauter, G., Widner, B. and Fuchs, D., More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin. Chem. 2002. 48: 579581.